每年研究計畫
個人檔案
學歷
- 2008 Rutgers UniversityPharmacology博士
- 1998 陽明大學生化碩士
- 1996 臺灣大學農業化學學士
經歷
- 2018- 臺北醫學大學癌症生物學與藥物研發研究所副教授
- 2018 臺北醫學大學癌症生物學與藥物研發博士學位學程副教授
- 2013-2018 臺北醫學大學癌症生物學與藥物研發博士學位學程助理教授
- 2009-2013 Princeton University博士後研究員
研究興趣
- 去氧核糖核酸受損訊息,
- 抗癌研究
- 疫苗研究
URL
指紋 查看啟用 Yuan-Chin Tsai 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 2 類似的檔案
Prostatic Neoplasms
Medicine & Life Sciences
Type I DNA Topoisomerase
Medicine & Life Sciences
Type II DNA Topoisomerase
Medicine & Life Sciences
Androgen Receptors
Medicine & Life Sciences
MicroRNAs
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Epithelial-Mesenchymal Transition
Medicine & Life Sciences
Antineoplastic Agents
Medicine & Life Sciences
網絡
國家層面的近期外部合作。點選圓點深入探索詳細資料。
研究成果 2004 2018
3
引文
(Scopus)
Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2
Tsai, Y. C., Chen, W. Y., Abou-Kheir, W., Zeng, T., Yin, J. J., Bahmad, H., Lee, Y. C. & Liu, Y. N., 五月 1 2018, 於 : Biochimica et Biophysica Acta - Molecular Basis of Disease. 1864, 5, p. 1717-1727 11 p.研究成果: 雜誌貢獻 › 文章
Activating Transcription Factors
CC Chemokines
Epithelial-Mesenchymal Transition
Androgens
Prostatic Neoplasms
2
引文
(Scopus)
A synergistic anti-cancer effect of troglitazone and lovastatin in a human anaplastic thyroid cancer cell line and in a mouse xenograft model
Zhong, W. B., Tsai, Y. C., Chin, L. H., Tseng, J. H., Tang, L. W., Horng, S., Fan, Y. C. & Hsu, S. P., 七月 1 2018, 於 : International Journal of Molecular Sciences. 19, 7, 1834.研究成果: 雜誌貢獻 › 文章
troglitazone
Lovastatin
cultured cells
Heterografts
mice
1
引文
(Scopus)
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. C., Zeng, T., Abou-Kheir, W., Yeh, H. L., Yin, J. J., Lee, Y. C., Chen, W. Y. & Liu, Y. N., 二月 19 2018, 於 : Molecular Cancer. 17, 1, 42.研究成果: 雜誌貢獻 › 文章
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
Prostatic Neoplasms
Genes
Castration
9
引文
(Scopus)
Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6
Tsai, Y. C., Chen, W. Y., Siu, M. K., Tsai, H. Y., Yin, J. J., Huang, J. & Liu, Y. N., 一月 1 2017, 於 : Cancer Letters. 384, p. 1-8 8 p.研究成果: 雜誌貢獻 › 文章
MicroRNAs
Epidermal Growth Factor Receptor
Prostatic Neoplasms
Down-Regulation
Neoplasms
9
引文
(Scopus)
Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis
Chen, W-Y., Tsai, Y-C., Siu, M. K., Yeh, H-L., Chen, C-L., Yin, J. J., Huang, J. & Liu, Y-N., 七月 10 2017, 於 : Oncogene. p. 6213-6224研究成果: 雜誌貢獻 › 文章
Androgen Receptors
Carcinogens
Prostatic Neoplasms
Neoplasm Metastasis
Epithelial-Mesenchymal Transition